Improving outcomes for children with cancer: targeted treatments and prevention

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1194264

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Child cancer is the commonest disease causing death in children. Relapse is due to small, treatment-resistant populations of cancer cells in the initial tumour. Improvements in cure rates have slowed due to poor investment by the pharmaceutical industry in targeting specific child cancer driver genes. My program of research will use novel technologies to identify: new vulnerabilities for combination drug therapies, drugs directed against child cancer gene targets and strategies for prevention.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Investigator Grants

Funding Amount: $900,000.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer prevention | combination therapy | drug discovery | paediatric

Related Links